COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study.

Autores da FMUP
Participantes de fora da FMUP
- Vigliar E
- Pisapia P
- Dello Iacovo F
- Alcaraz-Mateos E
- Alì G
- Ali SZ
- Baloch ZW
- Bellevicine C
- Bongiovanni M
- Botsun P
- Bruzzese D
- Bubendorf L
- Büttner R
- Canberk S
- Capitanio A
- Casadio C
- Cazacu E
- Cochand-Priollet B
- D'Amuri A
- Davis K
- Eloy C
- Engels M
- Fadda G
- Fontanini G
- Fulciniti F
- Hofman P
- Iaccarino A
- Ieni A
- Jiang XS
- Kakudo K
- Kern I
- Kholova I
- Linton McDermott KM
- Liu C
- Lobo A
- Lozano MD
- Malapelle U
- Maleki Z
- Michelow P
- Mikula MW
- Musayev J
- Özgün G
- Oznur M
- Peiró Marqués FM
- Poller D
- Pyzlak M
- Robinson B
- Rossi ED
- Roy-Chowdhuri S
- Saieg M
- Savic Prince S
- Seguí Iváñez FJ
- Štoos-Veic T
- Sulaieva O
- Sweeney BJ
- Tuccari G
- van Velthuysen ML
- VanderLaan PA
- Vielh P
- Viola P
- Voorham QJM
- Weynand B
- Zeppa P
- Faquin WC
- Pitman MB
- Troncone G
Unidades de investigação
Abstract
BACKGROUND: In a previous worldwide survey, the authors showed a drastic reduction in the number of cytological specimens processed during the coronavirus disease 2019 "lockdown" period along with an increase in malignancy rates. To assess the continued impact of the pandemic on cytological practices around the world, they undertook a second follow-up worldwide survey collecting data from the post-lockdown period (2020). METHODS: Participants were asked to provide data regarding their cytopathology activity during the first 12 weeks of their respective national post-lockdown period (2020), which ranged from April 4 to October 31. Differences between the post-lockdown period and the corresponding 2019 period were evaluated, and the authors specifically focused on rates of malignant diagnoses. RESULTS: A total of 29 respondents from 17 countries worldwide joined the survey. Overall, a lower number of cytological specimens (n = 236,352) were processed in comparison with the same period in 2019 (n = 321,466) for a relative reduction of 26.5%. The overall malignancy rate showed a statistically significant increase (12,442 [5.26%] vs 12,882 [4.01%]; P < .001) during the same time period. Similar results were obtained if both malignancy and suspicious for malignancy rates were considered together (15,759 [6.58%] vs 16,011 [4.98%]; P < .001). CONCLUSIONS: The data showed a persistent reduction in the cytological specimen volume during the post-lockdown period (2020). However, the relative increase in the cytological workload in the late part of the post-lockdown is a promising finding of a slow return to normality.
© 2022 American Cancer Society.
Dados da publicação
- ISSN/ISSNe:
- 1934-6638, 1934-6638
- Tipo:
- Article
- Páginas:
- 344-351
- DOI:
- 10.1002/cncy.22547
- Link para outro recurso:
- www.scopus.com
Cancer cytopathology Wiley-Blackwell
Citações Recebidas na Web of Science: 12
Citações Recebidas na Scopus: 16
Documentos
- Não há documentos
Filiações
Keywords
- cancer screening program; coronavirus disease 2019 (COVID-19); cytopathology; fine-needle aspiration; malignancy rate
Campos de estudo
Proyectos asociados
Parâmetros que demonstram ter influência na resposta à terapia neoadjuvante em pacientes com cancro da mama: Estado da arte e perspetivas futuras
Investigador Principal: Fernando Carlos de Landér Schmitt
Estudo Clínico Académico . 2021
Citar a publicação
Vigliar E,Pisapia P,Dello F,Alcaraz E,Alì G,Ali SZ,Baloch ZW,Bellevicine C,Bongiovanni M,Botsun P,Bruzzese D,Bubendorf L,Büttner R,Canberk S,Capitanio A,Casadio C,Cazacu E,Cochand B,D'Amuri A,Davis K,Eloy C,Engels M,Fadda G,Fontanini G,Fulciniti F,Hofman P,Iaccarino A,Ieni A,Jiang XS,Kakudo K,Kern I,Kholova I,Linton KM,Liu C,Lobo A,Lozano MD,Malapelle U,Maleki Z,Michelow P,Mikula MW,Musayev J,Özgün G,Oznur M,Peiró FM,Poller D,Pyzlak M,Robinson B,Rossi ED,Roy S,Saieg M,Savic S,Schmitt FC,Seguí FJ,Štoos T,Sulaieva O,Sweeney BJ,Tuccari G,van ML,VanderLaan PA,Vielh P,Viola P,Voorham QJM,Weynand B,Zeppa P,Faquin WC,Pitman MB,Troncone G. COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study. Cancer Cytopathol. 2022. 130. (5):p. 344-351. IF:3,400. (2).